Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Simvastatin + coenzyme Q10 is a combination therapy that pairs a cholesterol-lowering statin medication (simvastatin) with an antioxidant supplement (coenzyme Q10). This combination aims to maintain the cholesterol-lowering benefits of statins while potentially reducing statin-associated side effects, particularly muscle pain and weakness. Statins can lower the body's natural production of CoQ10, which some researchers believe contributes to muscle-related side effects. The combination therapy has shown promise in improving nitric oxide/reactive oxygen species balance in cardiovascular tissues and upregulating the Akt-eNOS pathway, which may represent a promising approach for treating cardiometabolic diseases.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on simvastatin + coenzyme q10.